Latest News in the pharma Industry

All

Eli Lilly streamline operation to affect 3500 workers

Eli Lilly streamline operation to affect 3500 workers

7 Sep 2017

Majority of the positions eliminated expected to come from a US voluntary early retirement program.

Read more 
Vectura and Pulmatrix sign branded generic tiotropium bromide development agreement

Vectura and Pulmatrix sign branded generic tiotropium bromide development agreement

6 Sep 2017

Major new tiotropium bromide DPI development programme accelerated through licensing of Pulmatrix technology.

Read more 
Life-extending pancreatic cancer medicine recommended by NICE in final guidance

Life-extending pancreatic cancer medicine recommended by NICE in final guidance

6 Sep 2017

The pivotal Phase III study demonstrated that treatment with Abraxane in combination with gemcitabine can offer patients a median overall survival improvement of 1.8 months.

Read more 
Merck to acquire Rigontec, RIG-I therapeutics pioneer, advancing leadership in immuno-oncology

Merck to acquire Rigontec, RIG-I therapeutics pioneer, advancing leadership in immuno-oncology

6 Sep 2017

Rigontec’s immuno-oncology approach of engaging the innate immune system to safely eliminate cancer cells complements Merck's strategy and current pipeline.

Read more 
Landmark Phase III trial shows fingolimod significantly reduces relapses in children and adolescents with MS

Landmark Phase III trial shows fingolimod significantly reduces relapses in children and adolescents with MS

6 Sep 2017

PARADIGMS is a first of its kind study in pediatric MS. Other current treatments have not been evaluated in head to head trials specifically designed for children and adolescents.

Read more 
Novartis CEO, Joseph Jimenez, to retire from Novartis in 2018

Novartis CEO, Joseph Jimenez, to retire from Novartis in 2018

5 Sep 2017

Vasant Narasimhan appointed CEO, effective 1February 2018.

Read more 
SGS Clinical Research strengthens its consultancy service to accelerate drugs through early phase development

SGS Clinical Research strengthens its consultancy service to accelerate drugs through early phase development

5 Sep 2017

Company consolidates its consultancy portfolio into a single, comprehensive offering.

Read more 
Catalent signs commercial manufacturing agreement with US WorldMeds for lofexidine

Catalent signs commercial manufacturing agreement with US WorldMeds for lofexidine

5 Sep 2017

Lofexidine is an investigational drug under development to mitigate symptoms associated with opioid withdrawal.

Read more 
Clintec expands UK headquarters and is presented with Queens Award for Enterprise – International Trade

Clintec expands UK headquarters and is presented with Queens Award for Enterprise – International Trade

5 Sep 2017

Company's additional 4327-sq ft floor at Clintec’s Glasgow-based headquarters forms a fully dedicated centre of excellence for clinical research and quality assurance capabilities.

Read more 
Takeda disappointed as NICE issue second negative draft decision for ixazomib

Takeda disappointed as NICE issue second negative draft decision for ixazomib

5 Sep 2017

Company says it is determined to work collaboratively to find a solution.

Read more 
Janssen enters exclusive distribution agreement for Invokana and Vokanamet

Janssen enters exclusive distribution agreement for Invokana and Vokanamet

4 Sep 2017

Distribution agreement covers countries in the EEA and Switzerland.

Read more 
Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly

Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly

4 Sep 2017

Midatech on track to start clinical development with MTD201 in Q4 2017.

Read more